Exploring Antibody Drug Conjugates in Cervical Cancer Treatment

https://vimeo.com/1070064657 Dr. Abigail Zamorano of McGovern Medical School at UT Health Houston explains how antibody drug conjugates (ADCs) are revolutionizing cervical cancer treatment. She discusses how these therapies deliver targeted chemotherapy…

CELMoDs Tomorrow

A panel of experts explore the potential of next-generation #myeloma treatments, focusing on Cereblon E3 ligase modulators (CELMoDs) and the critical need for equitable patient access. The panel includes: Dana…

Immunomodulators (IMDs) Today

A panel of experts discuss the bedrock therapy in multiple myeloma immunomodulators (IMDs). The panel includes: Jenny Ahlstrom – Founder and Chief Executive Officer, Healthtree Foundation Diane Moran – Business…

Tailored Multiple Myeloma Care

A panel of experts discuss strategies for how to best support multiple myeloma patients and their families during treatment. The panel includes: Diane Moran – Business Relationship Management, International Myeloma…

Can Self-Advocacy Close the Gap in Bladder Cancer Outcomes?

https://vimeo.com/1062233283 Bladder cancer research insights show disparities for specific groups. Expert Dr. Shaakir Hasan from Beth Israel Lahey Health discusses highlights from his research study, the value of seeking medical attention and…

Share On:

Facebook
Twitter
LinkedIn